- ChineseInvestors.com
is foremost financial information website for Chinese-speaking investors
in U.S. and China
- CIIX
subsidiary was featured in a recent Wall Street Journal report
on China’s growing cannabis industry
- ChineseInvestors.com
has highly diversified revenue streams that contribute to consistent,
stable growth
ChineseInvestors.com
Inc. (OTCQB: CIIX) offers an array of investor-education products and
services and has become a top financial-information website for
Chinese-speaking investors in the United States and China. At the heart of the
approach is the ChineseInvestors Method, an inventive integration of a
disciplined investing process, web-based tools, personalized instructions and
support. In addition, the company is working to capitalize on the increasing
demand for CBD (cannabidiol)-based nutrition and health products.
Established in 1999 and headquartered in San Gabriel,
California, ChineseInvestors.com provides real-time market commentary, analysis
and educational-related services in Chinese language character sets. In
addition, CIIX offers consultative services to smaller private companies
considering becoming a public company, as well as advertising and public-relations-related
support services. Furthermore, the company provides retail, online and direct
sales of hemp-based products and other health-related products.
Recently ChineseInvestors.com subsidiary, CBD Biotech Inc.,
was featured in a Wall Street Journal report on the growing
cannabis industry in China (http://ibn.fm/c4TUI).
The November 13 article was titled ‘China Says No to Marijuana but Lets Its
Cannabis Industry Bloom’.
According to the WSJ report, “The CBD
market will grow by 700% in the U.S. this year and will be worth more than $23
billion by 2023.” The report highlights CBD Biotech, which is a first mover in
the industrial hemp skin-care and cosmetics industry. CBD Biotech is working to
educate consumers on the benefits of industrial-hemp extract. Additionally,
this subsidiary is also positioning itself to be one of the leaders in China’s
legal market for skin-care products and cosmetics infused with cannabis sativa
leaf extract, or industrial hemp extract. Cannabis sativa leaf extract can
legally be added to skin-care and cosmetic products.
“As one of the first movers in the legal industrial hemp
skin-care and cosmetics market, we are honored to be featured in this
recent Wall Street Journal report and believe that this
mention validates our efforts in China over the past few years,” CBD Biotech
CEO Summer Yun stated in a news release.
ChineseInvestors.com has launched the world’s first online
CBD health-products store published in the Chinese language: www.ChineseCBDOil.com.
The company has done this under a wholesale agreement with a reputable CBD
health brand. Through this website, the company sells CBD-infused products by
way of online and in-store (http://ibn.fm/LTvQN).
Overall, ChineseInvestors.com’s plan is to focus on its
original mission of providing financial information and services to the larger
Chinese community in the United States and elsewhere. Of note to investors
regarding the company’s CBD initiatives is that ChineseInvestors.com CEO Warren
Wang indicated that the company hopes for a Nasdaq IPO of CBD Biotech late in
2019 or early 2020 (http://ibn.fm/kwEnA).
Following that, the company would concentrate on identifying an acquisition
target for further growth. FinTech products and services and CBD initiatives
contribute to the varied revenue streams of ChineseInvestors.com.
ChineseInvestors.com continues to help investors make
informed investment decisions and meet their individual financial goals. The
company is also at the vanguard of capitalizing on the convergence of CBD and
the nutrition- and health-products market in mainland China.
ChineseInvestors.com offers investors diverse revenue streams for potential
portfolio growth.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
